NCT07819214
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07819214
Title Epcoritamab as Consolidation Therapy for High-Risk Pts w/CLL on BTKI
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of California, Irvine
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Chao Family Comprehensive Cancer Center, University of California, Irvine Orange California 92868 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field